×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Lyra Therapeutics Inc. (LYRA) NASDAQ

$6.22 (0.31) (-4.75%)

Market Cap: $390.12M

As of 03/28/24 04:00 PM EDT. Market closed.

(LYRA)

Lyra Therapeutics Inc. (LYRA)
NASDAQ

$6.22
(0.31) (-4.75%)

Market Cap: $390.12M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

lyra therapeutics, inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. the company's xtreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. its ... read more

lyra therapeutics, inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. the company's xtreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. its product candidates include lyr-210 and lyr-220, which are bioresorbable polymeric matrices for the treatment of chronic rhinosinusitis. the company was formerly known as 480 biomedical, inc. and changed its name to lyra therapeutics, inc. in july 2018. lyra therapeutics, inc. was founded in 2005 and is headquartered in watertown, massachusetts. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
71
Address
.
PRICE CHART FOR LYRA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.61
Previous Close
$6.53
Days Range
$6.16 - $6.77
52 week range
$1.93 - $6.79
Volume
1,154,186
Avg. Volume (30 days)
331,000
Market Cap
$390.12M
Dividend Yield
-
P/E
(6.22)
Shares Outstanding
59,743,123
Open
$6.61
Previous Close
$6.53
Days Range
$6.16 - $6.77
52 week range
$1.93 - $6.79
Volume
1,154,186
Avg. Volume (30 days)
331,000
Market Cap
$390.12M
Dividend Yield
-
P/E
(6.22)
Shares Outstanding
59,743,123
FINANCIAL STATEMENTS FOR LYRA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR LYRA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Waksal HarlanExecutive ChairNov 10, 2023 Buy$2.9625,00074,095261,966Nov 13, 2023, 05:29 PM
NBVM GP, LLC10% OwnerMay 31, 2023 Buy$2.431,805,4164,387,1612,521,745Jun 02, 2023, 04:15 PM
ANDERSON EDWARD TDirectorMay 31, 2023 Buy$2.431,805,4164,387,1612,521,745Jun 02, 2023, 04:11 PM
PERCEPTIVE ADVISORS LLCDirectorMay 31, 2023 Buy$2.493,610,8328,999,99911,469,117Jun 02, 2023, 04:11 PM
MERRIFIELD C ANNDirectorJun 10, 2022 Buy$5.054,00020,20011,328Jun 13, 2022, 04:05 PM
MERRIFIELD C ANNDirectorMay 16, 2022 Buy$5.003281,6407,328May 17, 2022, 05:35 PM
MERRIFIELD C ANNDirectorMay 13, 2022 Buy$4.813,50016,8467,000May 17, 2022, 05:35 PM
PERCEPTIVE ADVISORS LLCDirectorApr 12, 2022 Buy$4.225,924,17024,999,9967,858,285Apr 14, 2022, 04:53 PM
NBVM GP, LLC10% OwnerApr 12, 2022 Buy$4.222,369,6679,999,9941,855,443Apr 14, 2022, 04:14 PM
ANDERSON EDWARD TDirectorApr 12, 2022 Buy$4.22118,483499,998118,483Apr 14, 2022, 04:08 PM
ANDERSON EDWARD TDirectorApr 12, 2022 Buy$4.222,369,6679,999,9941,855,443Apr 14, 2022, 04:08 PM
Waksal HarlanExecutive ChairApr 12, 2022 Buy$4.22236,966999,996236,966Apr 13, 2022, 07:16 PM
snyderman nancy lynn MDDirectorDec 16, 2020 Buy$9.721,0259,9631,025Dec 17, 2020, 04:05 PM
PERCEPTIVE ADVISORS LLCDirectorMay 05, 2020 Buy$16.00625,00010,000,0001,934,115May 29, 2020, 05:34 PM
Soleus Private Equity GP I, LLC10% OwnerMay 05, 2020 Buy$16.00155,0002,480,000155,000May 15, 2020, 06:16 PM
Soleus Private Equity GP I, LLC10% OwnerMay 05, 2020 Sale$16.0016,909270,544457,421May 15, 2020, 06:16 PM
Soleus Private Equity GP I, LLC10% OwnerMay 05, 2020 Option Exercise$8.6331,382270,827474,330May 15, 2020, 06:16 PM
PERCEPTIVE ADVISORS LLCDirectorMay 05, 2020 Option Exercise$16.00259,3464,149,5361,309,115May 06, 2020, 09:10 PM
PERCEPTIVE ADVISORS LLCDirectorMay 05, 2020 Option Exercise$8.63480,8254,149,5201,471,620May 06, 2020, 09:10 PM
NBVM GP, LLC10% OwnerMay 05, 2020 Buy$16.00250,0004,000,000778,592May 06, 2020, 07:38 PM
NBVM GP, LLC10% OwnerMay 05, 2020 Sale$16.0024,183386,928661,153May 06, 2020, 07:38 PM
NBVM GP, LLC10% OwnerMay 05, 2020 Option Exercise$8.6344,831386,892672,513May 06, 2020, 07:38 PM
ANDERSON EDWARD TDirectorMay 05, 2020 Buy$16.00250,0004,000,000778,592May 06, 2020, 07:32 PM
ANDERSON EDWARD TDirectorMay 05, 2020 Sale$16.0024,183386,928661,153May 06, 2020, 07:32 PM
ANDERSON EDWARD TDirectorMay 05, 2020 Option Exercise$8.6344,831386,892672,513May 06, 2020, 07:32 PM
Polaris Venture Management Co. V, L.L.C.10% OwnerMay 05, 2020 Buy$16.0062,5001,000,0001,062,259May 06, 2020, 07:30 PM
Polaris Venture Management Co. V, L.L.C.10% OwnerMay 05, 2020 Sale$16.009,674154,7841,001,951May 06, 2020, 07:30 PM
Polaris Venture Management Co. V, L.L.C.10% OwnerMay 05, 2020 Option Exercise$8.6317,932154,7531,011,285May 06, 2020, 07:30 PM
WHITESIDES GEORGE MDirectorMay 01, 2020 Option Exercise$16.0019,661314,57648,660May 01, 2020, 06:35 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Waksal HarlanExecutive Chair11/10/202374,095
NBVM GP, LLC10% Owner05/31/20234,387,161
ANDERSON EDWARD TDirector05/31/20234,387,161
PERCEPTIVE ADVISORS LLCDirector05/31/20238,999,999
MERRIFIELD C ANNDirector06/10/202220,200
MERRIFIELD C ANNDirector05/16/20221,640
MERRIFIELD C ANNDirector05/13/202216,846
PERCEPTIVE ADVISORS LLCDirector04/12/202224,999,996
NBVM GP, LLC10% Owner04/12/20229,999,994
ANDERSON EDWARD TDirector04/12/2022499,998
ANDERSON EDWARD TDirector04/12/20229,999,994
Waksal HarlanExecutive Chair04/12/2022999,996
snyderman nancy lynn MDDirector12/16/20209,963
PERCEPTIVE ADVISORS LLCDirector05/05/202010,000,000
Soleus Private Equity GP I, LLC10% Owner05/05/20202,480,000
Soleus Private Equity GP I, LLC10% Owner05/05/2020270,544
Soleus Private Equity GP I, LLC10% Owner05/05/2020270,827
PERCEPTIVE ADVISORS LLCDirector05/05/20204,149,536
PERCEPTIVE ADVISORS LLCDirector05/05/20204,149,520
NBVM GP, LLC10% Owner05/05/20204,000,000
NBVM GP, LLC10% Owner05/05/2020386,928
NBVM GP, LLC10% Owner05/05/2020386,892
ANDERSON EDWARD TDirector05/05/20204,000,000
ANDERSON EDWARD TDirector05/05/2020386,928
ANDERSON EDWARD TDirector05/05/2020386,892
Polaris Venture Management Co. V, L.L.C.10% Owner05/05/20201,000,000
Polaris Venture Management Co. V, L.L.C.10% Owner05/05/2020154,784
Polaris Venture Management Co. V, L.L.C.10% Owner05/05/2020154,753
WHITESIDES GEORGE MDirector05/01/2020314,576
Load More Insider Transactions
FUNDS WITH A POSITION IN LYRA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC336,4580.00018%9%Other
BLACKROCK INC.110,7970.00001%133.35%Other
RENAISSANCE TECHNOLOGIES LLC43,9000.00036%-11.85%Other
BALYASNY ASSET MANAGEMENT L.P.28,7950.00028%NewEvent Driven
CHANGE IN SHARES OUTSTANDING FOR LYRA THERAPEUTICS INC
STOCK BUYBACKS FOR LYRA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
-12.55%
1Q
12/31/2023
06/30/2023
14.03%
2Q
12/31/2023
03/31/2023
35.22%
3Q
12/31/2023
09/30/2022
35.24%
5Q
12/31/2023
06/30/2022
46.71%
6Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
-12.55%
1Q
06/30/2023
14.03%
2Q
03/31/2023
35.22%
3Q
09/30/2022
35.24%
5Q
06/30/2022
46.71%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR LYRA THERAPEUTICS INC
LOADING...